XClose

UCL Division of Surgery and Interventional Science

Home
Menu

Landmark Publications

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V. Kasivisvanathan, A.S. Rannikko, M. Borghi, V. Panebianco, L.A. Mynderse, M.H. Vaarala, A. Briganti, L. Budäus, G. Hellawell, R.G. Hindley, M.J. Roobol, S. Eggener, M. Ghei, A. Villers, F. Bladou, G.M. Villeirs, J. Virdi, S. Boxler, G. Robert, P.B. Singh, W. Venderink, B.A. Hadaschik, A. Ruffion, J.C. Hu, D. Margolis, S. Crouzet, L. Klotz, S.S. Taneja, P. Pinto, I. Gill, C. Allen, F. Giganti, A. Freeman, S. Morris, S. Punwani, N.R. Williams, C. Brew-Graves, J. Deeks, Y. Takwoingi, M. Emberton, and C.M. Moore, for the PRECISION Study Group Collaborators (2018):'MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis' The New England Journal of Medicine, doi: 10.1056/NEJMoa1801993

 

issuu Widget Placeholder33644033/62036842

 
Effect of Anastrozole and Tamoxifen as adjuvant treatment for early stage breast cancer: 100-month analysis of the ATAC trial
Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M.  (2008). Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. The Lancet Oncology, Volume 9, Issue 1, pages 45-53. doi: https://doi.org/10.1016/S1470-2045(07)70385-6

issuu Widget Placeholder19240667/66250252

 
 
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, Suetterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HMR, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M on behalf of the TARGIT trialist's group (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. The Lancet, Volume 383, Issue 9917, pages 603-613, DOI: https://doi.org/10.1016/S0140-6736(13)61950-9

 

issuu Widget Placeholder19240667/66250279
 
Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group
Current Trials Working Party of the Cancer Research Campaign Breast Cancer Trials Group (1996). Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group. Journal of the National Cancer Institute

issuu Widget Placeholder19240667/66250341